Search results
Prime Medicine, Inc. (NYSE:PRME) Forecasted to Earn FY2024 Earnings of ($1.68) Per Share
ETF DAILY NEWS· 4 days agoPrime Medicine, Inc. (NYSE:PRME – Free Report) – Analysts at Chardan Capital issued their FY2024 earnings per share (EPS) estimates for shares of Prime Medicine< ...
Science Says Women Are Smarter When They're On Their Periods
Women's Health via Yahoo News· 57 minutes agoA new study published in the journal 'Neuropsychologia' found that participants had faster reaction...
Construction begins on WellSpan’s Pennsylvania medical campus
Hospital Management via Yahoo Finance· 3 hours agoThese services will complement existing cardiology, ENT, and urology services in the area. WellSpan...
Researcher helps advance 'Food is Medicine' concept to reach nutrition security goals
Medical Xpress· 2 days ago"Food is Medicine can encompass a variety of interventions." The White House Conference on Hunger,...
Rapport Therapeutics raises up to $154 million in IPO - Boston Business Journal
The Business Journals· 1 hour agoRapport Therapeutics Inc. said late Thursday it has raised $154 million in an initial public offering. Rapport (Nasdaq: RAPP), a Boston-based maker of small-molecule medicines
Fullpower®-AI Announces Groundbreaking Sleep Studies Presented at the SLEEP 2024 Conference in...
Yucaipa News Mirror· 1 day agoFullpower Technologies, in collaboration with Stanford Sleep Medicine and UCSF Department of Psychiatry and Behavioral Sciences, presented two major studies at the SLEEP 2024 ...
Jacksonville Sports Medicine Program celebrates 40th anniversary
First Coast News· 2 days agoThe Jacksonville Sports Medicine Program (JSMP) celebrated its 40th anniversary with an awards...
Resisting the backlash against equity in medicine will improve health outcomes for all
The Conversation· 1 day agoA backlash against EDIA (equity, diversity, inclusion and accessibility) is gripping Canadian medicine. This is no surprise for a historically conservative institution, but ...
Qu Biologics and Foundation Medicine Collaborate to Impact the Care of Patients with Late-Stage...
Digital Journal· 24 hours agoBiologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, and ...
Michigan Central Station, while empty, was a classroom, a blank canvas, a refuge for youths
Detroit Free Press via Yahoo News· 2 hours agoThey missed the outdoors, and his father left to build a career in landscaping. His hardworking...